Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Identifying and classifying opioid-related overdoses: A validation study.

Green CA, Perrin NA, Hazlehurst B, Janoff SL, DeVeaugh-Geiss A, Carrell DS, Grijalva CG, Liang C, Enger CL, Coplan PM.

Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1127-1137. doi: 10.1002/pds.4772. Epub 2019 Apr 24.

PMID:
31020755
2.

Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review.

Brandenburg NA, Phillips S, Wells KE, Woodcroft KJ, Amend KL, Enger C, Oliveria SA.

Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):256-263. doi: 10.1002/pds.4711. Epub 2019 Feb 4.

PMID:
30719785
3.

A Survey of Patients' Perceptions of Pill Appearance and Responses to Changes in Appearance for Four Chronic Disease Medications.

Sarpatwari A, Gagne JJ, Lu Z, Campbell EG, Carman WJ, Enger CL, Dutcher SK, Jiang W, Kesselheim AS.

J Gen Intern Med. 2019 Mar;34(3):420-428. doi: 10.1007/s11606-018-4791-1. Epub 2019 Jan 10.

PMID:
30632102
4.

Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.

Mortimer K, Hartmann N, Chan C, Norman H, Wallace L, Enger C.

BMC Pulm Med. 2019 Jan 10;19(1):11. doi: 10.1186/s12890-018-0759-5.

5.

Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans.

Hoffman V, Abu-Elyazeed R, Enger C, Esposito DB, Doherty MC, Quinlan SC, Skerry K, Holick CN, Basile P, Friedland LR, Praet N, Wéry S, Willame C, Dore DD, Rosillon D.

Hum Vaccin Immunother. 2018 Jul 3;14(7):1782-1790. doi: 10.1080/21645515.2018.1450123. Epub 2018 Apr 13.

6.

Assessment of Risk Evaluation and Mitigation Strategies (REMS) for varenicline (Chantix): A multistage patient survey.

Amend KL, Younus M, Petronis KR, Mo J, Seeger JD, Gately R, Gu X, Enger C.

Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):253-262. doi: 10.1002/pds.4373. Epub 2018 Feb 6.

PMID:
29405516
7.

Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use.

Carman WJ, Accortt NA, Anthony MS, Iles J, Enger C.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1109-1118. doi: 10.1002/pds.4261. Epub 2017 Jul 31.

PMID:
28758274
8.

Diagnosed cataracts in patients with cystic fibrosis in a United States administrative database.

Everage NJ, Bai Y, Loop B, Volkova N, Liu N, Enger C.

Ophthalmic Genet. 2017 Dec;38(6):527-532. doi: 10.1080/13816810.2017.1301964. Epub 2017 Apr 10.

PMID:
28394650
9.
10.

Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.

Hoffman V, Xue F, Gardstein B, Skerry K, Critchlow CW, Enger C.

Osteoporos Int. 2016 Apr;27(4):1653-1658. doi: 10.1007/s00198-015-3402-9. Epub 2015 Nov 11.

PMID:
26558380
11.

Development and evaluation of an algorithm to identify users of Prolia(®) during the early postmarketing period using health insurance claims data.

Hoffman V, Xue F, Gardstein B, Skerry K, Critchlow CW, Enger C.

Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):993-8. doi: 10.1002/pds.3680. Epub 2014 Jul 23.

PMID:
25052047
12.

Thromboembolic events among patients with hepatitis C virus infection and cirrhosis: a matched-cohort study.

Enger C, Forssen UM, Bennett D, Theodore D, Shantakumar S, McAfee A.

Adv Ther. 2014 Aug;31(8):891-903. doi: 10.1007/s12325-014-0138-4. Epub 2014 Jul 22.

PMID:
25047758
13.

The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey.

Enger C, Younus M, Petronis KR, Mo J, Gately R, Seeger JD.

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):705-15. doi: 10.1002/pds.3400. Epub 2013 Jan 24.

PMID:
23349095
14.

Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia.

Enger C, Jones ME, Kryzhanovskaya L, Doherty M, McAfee AT.

Int J Adolesc Med Health. 2013;25(1):3-11. doi: 10.1515/ijamh-2013-0002.

PMID:
23337048
15.

Risk of mortality, fatal infection, and fatal malignancy related to use of anti-tumor necrosis factor-α biologics by rheumatoid arthritis patients.

Thyagarajan V, Norman H, Alexander KA, Napalkov P, Enger C.

Semin Arthritis Rheum. 2012 Dec;42(3):223-33. doi: 10.1016/j.semarthrit.2012.05.004. Epub 2012 Jun 28.

PMID:
22748510
16.

Hepatobiliary laboratory abnormalities among patients with chronic or persistent immune thrombocytopenia (ITP).

Enger C, Bennett D, Dawson KL, Aivado MA, Theodore D, McAfee AT.

Ann Hepatol. 2011 Apr-Jun;10(2):188-95.

17.

Pharmacoepidemiology safety study of fibrate and statin concomitant therapy.

Enger C, Gately R, Ming EE, Niemcryk SJ, Williams L, McAfee AT.

Am J Cardiol. 2010 Dec 1;106(11):1594-601. doi: 10.1016/j.amjcard.2010.07.041. Epub 2010 Oct 14.

PMID:
21094360
18.

Comorbidities in patients with persistent or chronic immune thrombocytopenia.

Enger C, Bennett D, Forssen U, Fogarty PF, McAfee AT.

Int J Hematol. 2010 Sep;92(2):289-95. doi: 10.1007/s12185-010-0636-3. Epub 2010 Jul 24.

PMID:
20652840
19.

Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. 1992.

Green WR, Enger C.

Retina. 2005 Jul-Aug;25(5 Suppl):1519-35. No abstract available.

PMID:
16049370
20.

Idiopathic epiretinal membranes: ultrastructural characteristics and clinicopathologic correlation. 1989.

Smiddy WE, Maguire AM, Green WR, Michels RG, de la Cruz Z, Enger C, Jaeger M, Rice TA.

Retina. 2005 Jul-Aug;25(5 Suppl):811-20; discussion 821. No abstract available.

PMID:
16049366
21.

Health outcomes among patients receiving oseltamivir.

Enger C, Nordstrom BL, Thakrar B, Sacks S, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2004 Apr;13(4):227-37.

PMID:
15255089
22.

Serious cardiovascular events and mortality among patients with schizophrenia.

Enger C, Weatherby L, Reynolds RF, Glasser DB, Walker AM.

J Nerv Ment Dis. 2004 Jan;192(1):19-27.

PMID:
14718772
23.

Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States.

Enger C, Cali C, Walker AM.

Pharmacoepidemiol Drug Saf. 2002 Sep;11(6):477-86.

PMID:
12426932
24.

Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.

Wilson MR, Kosoko O, Cowan CL Jr, Sample PA, Johnson CA, Haynatzki G, Enger C, Crandall D.

Am J Ophthalmol. 2002 Sep;134(3):399-405.

PMID:
12208252
25.

Acute bleeding and thrombocytopenia after bone marrow transplantation.

Nevo S, Enger C, Hartley E, Borinsky ME, Swan V, Fuller AK, Braine HG, Kickler TS, George JN, Vogelsang GB.

Bone Marrow Transplant. 2001 Jan;27(1):65-72.

26.
27.

Diagnosis of renal cancer by molecular urinalysis.

Eisenberger CF, Schoenberg M, Enger C, Hortopan S, Shah S, Chow NH, Marshall FF, Sidransky D.

J Natl Cancer Inst. 1999 Dec 1;91(23):2028-32.

PMID:
10580028
28.

Bilateral prophylactic mastectomy decision making: A vignette study.

Stefanek M, Enger C, Benkendorf J, Flamm Honig S, Lerman C.

Prev Med. 1999 Sep;29(3):216-21.

PMID:
10479610
29.

Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men.

Keet IP, Tang J, Klein MR, LeBlanc S, Enger C, Rivers C, Apple RJ, Mann D, Goedert JJ, Miedema F, Kaslow RA.

J Infect Dis. 1999 Aug;180(2):299-309.

PMID:
10395843
30.

Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem.

Selnes OA, Goldsborough MA, Borowicz LM Jr, Enger C, Quaskey SA, McKhann GM.

Ann Thorac Surg. 1999 Jun;67(6):1669-76.

PMID:
10391273
32.

Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival.

Nevo S, Enger C, Swan V, Wojno KJ, Fuller AK, Altomonte V, Braine HG, Noga SJ, Vogelsang GB.

Transplantation. 1999 Mar 15;67(5):681-9.

PMID:
10096522
33.

Comparison of viral load and human leukocyte antigen statistical and neural network predictive models for the rate of HIV-1 disease progression across two cohorts of homosexual men.

Ioannidis JP, Goedert JJ, McQueen PG, Enger C, Kaslow RA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Feb 1;20(2):129-36.

PMID:
10048899
34.

Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study.

Saah AJ, Hoover DR, Weng S, Carrington M, Mellors J, Rinaldo CR Jr, Mann D, Apple R, Phair JP, Detels R, O'Brien S, Enger C, Johnson P, Kaslow RA.

AIDS. 1998 Nov 12;12(16):2107-13.

PMID:
9833851
35.

Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic.

Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM.

Ophthalmology. 1998 Nov;105(11):2105-11.

PMID:
9818613
36.

Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.

Jabs DA, Enger C, Dunn JP, Forman M, Hubbard L.

Am J Ophthalmol. 1998 Oct;126(4):543-9.

PMID:
9780099
38.

Inhibited apoptosis and drug resistance in acute myeloid leukaemia.

Smith BD, Bambach BJ, Vala MS, Barber JP, Enger C, Brodsky RA, Burke PJ, Gore SD, Jones RJ.

Br J Haematol. 1998 Sep;102(4):1042-9.

PMID:
9734656
39.

Stereotactic radiosurgery for brain metastases: comparison of lung carcinoma vs. non-lung tumors.

Williams J, Enger C, Wharam M, Tsai D, Brem H.

J Neurooncol. 1998 Mar;37(1):79-85.

PMID:
9525842
40.
41.

Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients.

Nevo S, Swan V, Enger C, Wojno KJ, Bitton R, Shabooti M, Fuller AK, Jones RJ, Braine HG, Vogelsang GB.

Blood. 1998 Feb 15;91(4):1469-77.

42.

Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.

Kensler TW, He X, Otieno M, Egner PA, Jacobson LP, Chen B, Wang JS, Zhu YR, Zhang BC, Wang JB, Wu Y, Zhang QN, Qian GS, Kuang SY, Fang X, Li YF, Yu LY, Prochaska HJ, Davidson NE, Gordon GB, Gorman MB, Zarba A, Enger C, Muñoz A, Helzlsouer KJ, et al.

Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):127-34.

43.

Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients.

Abrams RA, Cardinale RM, Enger C, Haulk TL, Hurwitz H, Osterman F, Sitzmann JV.

Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1077-85.

PMID:
9392547
44.

Prospective, randomized vector analysis of astigmatism after three-, one-, and no-suture phacoemulsification.

Azar DT, Stark WJ, Dodick J, Khoury JM, Vitale S, Enger C, Reed C.

J Cataract Refract Surg. 1997 Oct;23(8):1164-73.

PMID:
9368159
45.

T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients.

Tay-Kearney ML, Enger C, Semba RD, Royal W 3rd, Dunn JP, Jabs DA.

J Infect Dis. 1997 Sep;176(3):790-4.

PMID:
9291335
46.

Depression and cognitive decline after coronary artery bypass grafting.

McKhann GM, Borowicz LM, Goldsborough MA, Enger C, Selnes OA.

Lancet. 1997 May 3;349(9061):1282-4.

PMID:
9142062
47.

Short course radiotherapy is an appropriate option for most malignant glioma patients.

Kleinberg L, Slick T, Enger C, Grossman S, Brem H, Wharam MD Jr.

Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):31-6.

PMID:
9212001
48.

Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.

Jacobson LP, Zhang BC, Zhu YR, Wang JB, Wu Y, Zhang QN, Yu LY, Qian GS, Kuang SY, Li YF, Fang X, Zarba A, Chen B, Enger C, Davidson NE, Gorman MB, Gordon GB, Prochaska HJ, Egner PA, Groopman JD, Muñoz A, Helzlsouer KJ, Kensler TW.

Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):257-65.

49.

Viral resistance and CMV retinitis: design and methods of a prospective study. CRVR Research Groups. Cytomegalovirus Retinitis Viral Resistance Research Group.

Enger C, Jabs DA, Dunn JP, Forman MS, Bressler NM, Margolick JB, Charache P.

Ophthalmic Epidemiol. 1997 Mar;4(1):41-8.

PMID:
9145415
50.

Cognitive outcome after coronary artery bypass: a one-year prospective study.

McKhann GM, Goldsborough MA, Borowicz LM Jr, Selnes OA, Mellits ED, Enger C, Quaskey SA, Baumgartner WA, Cameron DE, Stuart RS, Gardner TJ.

Ann Thorac Surg. 1997 Feb;63(2):510-5.

PMID:
9033329

Supplemental Content

Support Center